Analogue-based drug discovery III /

Uloženo v:
Podrobná bibliografie
Další autoři: Fischer, János, 1945- (Editor), Ganellin, C. R. 1934- (Editor), Rotella, David P. (Editor)
Typ dokumentu: Kniha
Jazyk:Angličtina
Vydáno: Weinheim : Wiley-VCH, [2013]
Témata:
On-line přístup:Elektronická verze přístupná pouze pro studenty a pracovníky MU
Příbuzné jednotky:Tištěná verze:: Analogue-based drug discovery III.
Obsah:
  • General Aspects. Pioneer and Analogue Drugs /
  • Janos Fischer, C Robin Ganellin, David P Rotella
  • Competition in the Pharmaceutical Drug Development /
  • Christian Tyrchan, Fabrizio Giordanetto
  • Metabolic Stability and Analogue-Based Drug Discovery /
  • Amit S Kalgutkar, Antonia F Stepan
  • Use of Macrocycles in Drug Design Exemplified with Ulimorelin, a Potential Ghrelin Agonist for Gastrointestinal Motility Disorders /
  • Mark L Peterson, Hamid Hoveyda, Graeme Fraser, Eric Marsault, Rene Gagnon
  • Drug Classes. The Discovery of Anticancer Drugs Targeting Epigenetic Enzymes /
  • A Ganesan
  • Thienopyridyl and Direct-Acting P2Y Receptor Antagonist Antiplatelet Drugs /
  • Joseph A Jakubowski, Atsuhiro Sugidachi
  • Selective Estrogen Receptor Modulators /
  • Amarjit Luniwal, Rachael Jetson, Paul Erhardt
  • Discovery of Nonpeptide Vasopressin V2 Receptor Antagonists /
  • Kazumi Kondo, Hidenori Ogawa
  • The Development of Cysteinyl Leukotriene Receptor Antagonists /
  • Peter R Bernstein
  • Case Studies. The Discovery of Dabigatran Etexilate /
  • Norbert Hauel, Andreas Clemens, Herbert Nar, Henning Priepke, Joanne van Ryn, Wolfgang Wienen
  • The Discovery of Citalopram and Its Refinement to Escitalopram /
  • Klaus P Bogeso, Connie Sanchez
  • Tapentadol : From Morphine and Tramadol to the Discovery of Tapentadol /
  • Helmut Buschmann
  • Novel Taxanes: Cabazitaxel Case Study /
  • Herve Bouchard, Dorothee Semiond, Marie-Laure Risse, Patricia Vrignaud
  • Discovery of Boceprevir and Narlaprevir: A Case Study for Role of Structure-Based Drug Design /
  • Srikanth Venkatraman, Andrew Prongay, George F Njoroge
  • A New-Generation Uric Acid Production Inhibitor: Febuxostat /
  • Ken Okamoto, Shiro Kondo, Takeshi Nishino.